Seroepidemiologic Survey of Epidemic Cholera in Haiti to Assess Spectrum of Illness and Risk Factors for Severe Disease
暂无分享,去创建一个
Gordana Derado | Brendan R. Jackson | Peter Gerner-Smidt | Elsie Lafosse | Jacques Boncy | B. Jackson | P. Gerner-Smidt | J. Tappero | W. Hooper | Elsie Lafosse | J. Boncy | E. Mintz | R. Magloire | G. Dahourou | D. Talkington | G. Gómez | A. Payne | W. Archer | Jordan W. Tappero | Eric D. Mintz | W. Craig Hooper | B. Nygren | Benjamin Nygren | Gerardo A. Gómez | Deborah F. Talkington | Roc Magloire | James M. Pruckler | M. D. Bernadette Fouché | Georges A. Dahourou | W. Roodly Archer | Amanda B. Payne | Nicole Freeman | J. Pruckler | M. Fouché | N. Freeman | G. Derado | Elsie Fouché | Benjamin Lafosse | Gerardo A Nygren | Georges A Gó Mez | W. Dahourou | Amanda B Roodly Archer | W. C. Payne | Jordan W Hooper | Gordana Tappero | Roc Derado | Peter Magloire | Nicole Gerner-Smidt | Jacques Freeman | Eric D Boncy | Cholera Mintz | Working Serosurvey | Group | Group
[1] W H Mosley,et al. Seroepidemiologic studies during a simultaneous epidemic of infection with El Tor Ogawa and classical Inaba Vibrio cholerae. , 1970, The Journal of infectious diseases.
[2] J. Wells,et al. Cholera in the United States, 1995-2000: trends at the end of the twentieth century. , 2001, The Journal of infectious diseases.
[3] J. Wrammert,et al. Antigen-Specific Memory B-Cell Responses to Vibrio cholerae O1 Infection in Bangladesh , 2009, Infection and Immunity.
[4] G. Nair,et al. Evolution of new variants of Vibrio cholerae O1. , 2010, Trends in microbiology.
[5] D. Jenson,et al. Cholera in Haiti and Other Caribbean Regions, 19th Century , 2011, Emerging infectious diseases.
[6] B. Stoll,et al. Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. , 1985, American journal of epidemiology.
[7] S. Roy,et al. Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial , 2008, BMJ : British Medical Journal.
[8] David M. Hartley,et al. Hyperinfectivity: A Critical Element in the Ability of V. cholerae to Cause Epidemics? , 2005, PLoS medicine.
[9] Gary Van Domselaar,et al. Comparative Genomics of Vibrio cholerae from Haiti, Asia, and Africa , 2011, Emerging infectious diseases.
[10] D. Swerdlow,et al. Cholera in the Americas. Guidelines for the clinician. , 1992, JAMA.
[11] P. Gerner-Smidt,et al. Characterization of Toxigenic Vibrio cholerae from Haiti, 2010–2011 , 2011, Emerging infectious diseases.
[12] M. Levine,et al. Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology. , 1981, American journal of epidemiology.
[13] David A. Sack,et al. Blood Group, Immunity, and Risk of Infection with Vibrio cholerae in an Area of Endemicity , 2005, Infection and Immunity.
[14] D. Palmer,et al. Nutritional status: a determinant of severity of diarrhea in patients with cholera. , 1976, The Journal of infectious diseases.
[15] D. Swerdlow,et al. Severe life-threatening cholera associated with blood group O in Peru: implications for the Latin American epidemic. , 1994, The Journal of infectious diseases.
[16] M. Levine,et al. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. , 1982, The Journal of infectious diseases.
[17] S. Yamasaki,et al. Cholera Toxin Production by the El Tor Variant of Vibrio cholerae O1 Compared to Prototype El Tor and Classical Biotypes , 2010, Journal of Clinical Microbiology.
[18] M. Toole,et al. Cholera deaths in Goma , 1995, The Lancet.
[19] B. Stoll,et al. Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine. , 1989, The Pediatric infectious disease journal.
[20] E. Pissimissis,et al. Public health impact of Rwandan refugee crisis : what happened in Goma , Zaire , in July , 1994 ? , 2004 .
[21] D. Nalin,et al. CHOLERA, NON-VIBRIO CHOLERA, AND STOMACH ACID , 1978, The Lancet.
[22] Firdausi Qadri,et al. Susceptibility to Vibrio cholerae Infection in a Cohort of Household Contacts of Patients with Cholera in Bangladesh , 2008, PLoS neglected tropical diseases.
[23] R. Glass,et al. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. , 1985, The Journal of infectious diseases.
[24] J. Tappero,et al. Cholera surveillance during the Haiti epidemic--the first 2 years. , 2013, The New England journal of medicine.
[25] W. Dzik,et al. The ABO blood group system and Plasmodium falciparum malaria. , 2007, Blood.
[26] C. Black,et al. Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes. , 1984, Hybridoma.
[27] D. Sack,et al. Low gastric acid as a risk factor for cholera transmission: application of a new non-invasive gastric acid field test. , 1990, Journal of clinical epidemiology.
[28] A. Nizam,et al. El Tor cholera with severe disease: a new threat to Asia and beyond , 2009, Epidemiology and Infection.